Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction

Blood Reviews

Volumn 26, Issue 6, 2012, Pages 255-259

  Gardiner, Elizabeth E ^a   Andrews, Robert K ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Infection; Neutrophils; Platelets; Vascular biology

Indexed keywords

CATHEPSIN G; GLYCOPROTEIN IB ALPHA; HEPARIN; HEPARIN DERIVATIVE; HISTONE H3; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ELASTASE; SERINE PROTEINASE; THROMBIN; THROMBOCYTE FACTOR 4; WARFARIN;

ARTICLE; BACTERIAL INFECTION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; NEUTROPHIL EXTRACELLULAR TRAP; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; THROMBOSIS; VASCULAR DISEASE; VENOUS THROMBOEMBOLISM;

ANIMALS; BACTERIAL INFECTIONS; BLOOD PLATELETS; HUMANS; IMMUNITY, INNATE; NEUTROPHIL ACTIVATION; NEUTROPHILS; THROMBOSIS;

EID: 84868214402     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2012.09.001     Document Type: Article

References (74)

1. Westheimer F.H. Why nature chose phosphates. Science 1987, 235:1173-1178.
2. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
3. Borissoff J.I., ten Cate H. From neutrophil extracellular traps release to thrombosis: an overshooting host-defense mechanism?. J Thromb Haemost 2011, 9:1791-1794.
4. Gardiner E.E., Ward C.M., Andrews R.K. The NET effect of clot formation. J Thromb Haemost 2012, 10:133-135.
5. Fuchs T.A., Brill A., Wagner D.D. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol 2012, 32:1777-1783.
6. Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010, 107:15880-15885.
7. Brill A., Fuchs T.A., Savchenko A.S., Thomas G.M., Martinod K., De Meyer S.F., et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012, 10:136-144.
8. von Bruhl M.L., Stark K., Steinhart A., Chandraratne S., Konrad I., Lorenz M., et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012, 209:819-835.
9. Lee W.L., Grinstein S. The tangled webs that neutrophils weave. Science 2004, 303:1477-1478.
10. Hakkim A., Fuchs T.A., Martinez N.E., Hess S., Prinz H., Zychlinsky A., et al. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol 2010, 7:75-77.
11. Worth L.J., Slavin M.A. Bloodstream infections in haematology: risks and new challenges for prevention. Blood Rev 2009, 23:113-122.
12. Cox D., Kerrigan S.W., Watson S.P. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 2011, 9:1097-1107.
13. Pham C.T. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 2006, 6:541-550.
14. Menegazzi R., Decleva E., Dri P. Killing by neutrophil extracellular traps: fact or folklore?. Blood 2012, 119:1214-1216.
15. Hu H., Armstrong P.C., Khalil E., Chen Y.C., Straub A., Li M., et al. GPVI and GPIbα mediate Staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS One 2011, 6:e19190.
16. 3. J Thromb Haemost 2009, 7:1867-1874.
17. Andrews R.K., Berndt M.C. Platelet physiology and thrombosis. Thromb Res 2004, 114:447-453.
18. Vandendries E.R., Furie B.C., Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 2004, 92:459-466.
19. Cerletti C., Tamburrelli C., Izzi B., Gianfagna F., de Gaetano G. Platelet-leukocyte interactions in thrombosis. Thromb Res 2012, 129:263-266.
20. Pouyani T., Seed B. PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell 1995, 83:333-343.
21. Wilkins P.P., Moore K.L., McEver R.P., Cummings R.D. Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J Biol Chem 1995, 270:22677-22680.
22. De Luca M., Dunlop L.C., Andrews R.K., Flannery J.V., Ettling R., Cumming D.A., et al. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J Biol Chem 1995, 270:26734-26737.
23. Andrews R.K., Lopez J.A., Berndt M.C. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997, 29:91-105.
24. Simon D.I., Chen Z., Xu H., Li C.Q., Dong J., McIntire L.V., et al. Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000, 192:193-204.
25. Gardiner E.E., De Luca M., McNally T., Michelson A.D., Andrews R.K., Berndt M.C. Regulation of P-selectin binding to the neutrophil P-selectin counter-receptor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G. Blood 2001, 98:1440-1447.
26. LaRosa C.A., Rohrer M.J., Benoit S.E., Barnard M.R., Michelson A.D. Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP)Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIbα and by a cytoskeletal-mediated redistribution of the remainder of the complex. Blood 1994, 84:158-168.
27. LaRosa C.A., Rohrer M.J., Benoit S.E., Rodino L.J., Barnard M.R., Michelson A.D. Human neutrophil cathepsin G is a potent platelet activator. J Vasc Surg 1994, 19:306-318. [discussion 18-9].
28. Andrews R., Berndt M., Lopez J. The glycoprotein Ib-IX-V complex. Platelets 2006, 145-164. Academic Press, San Diego, CA. 2nd ed. A.D. Michelson (Ed.).
29. Arthur J.F., Gardiner E.E., Matzaris M., Taylor S.G., Wijeyewickrema L., Ozaki Y., et al. Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost 2005, 93:716-723.
30. Andrews R.K., Berndt M.C. Platelet adhesion: a game of catch and release. J Clin Invest 2008, 118:3009-3011.
31. Yago T., Lou J., Wu T., Yang J., Miner J.J., Coburn L., et al. Platelet glycoprotein Ibα forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest 2008, 118:3195-3207.
32. Kim J., Zhang C.Z., Zhang X., Springer T.A. A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature 2010, 466:992-995.
33. Romo G.M., Dong J.F., Schade A.J., Gardiner E.E., Kansas G.S., Li C.Q., et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999, 190:803-814.
34. Zarpellon A., Celikel R., Roberts J.R., McClintock R.A., Mendolicchio G.L., Moore K.L., et al. Binding of α-thrombin to surface-anchored platelet glycoprotein Ibα sulfotyrosines through a two-site mechanism involving exosite I. Proc Natl Acad Sci U S A 2011, 108:8628-8633.
35. De Candia E., Hall S.W., Rutella S., Landolfi R., Andrews R.K., De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. J Biol Chem 2001, 276:4692-4698.
36. Baglia F.A., Shrimpton C.N., Emsley J., Kitagawa K., Ruggeri Z.M., Lopez J.A., et al. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibα on the activated platelet. J Biol Chem 2004, 279:49323-49329.
37. Bradford H.N., Pixley R.A., Colman R.W. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem 2000, 275:22756-22763.
38. 3/GPVI-dependent pathway. Am J Pathol 2010, 177:1131-1142.
39. Ramakrishnan V., DeGuzman F., Bao M., Hall S.W., Leung L.L., Phillips D.R. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci U S A 2001, 98:1823-1828.
40. Bock P.E., Panizzi P., Verhamme I.M. Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost 2007, 5(Suppl. 1):81-94.
41. Renne T. The procoagulant and proinflammatory plasma contact system. Semin Immunopathol 2012, 34:31-41.
42. Muller F., Mutch N.J., Schenk W.A., Smith S.A., Esterl L., Spronk H.M., et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009, 139:1143-1156.
43. Andrews R.K., Berndt M.C. Microparticles facilitate neutrophil/platelet crosstalk. Blood 2008, 112:2174-2175.
44. 2 (Mac-1) on neutrophil-derived microparticles. Blood 2008, 112:2327-2335.
45. Gailani D., Renne T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 2007, 27:2507-2513.
46. Piersma S.R., Broxterman H.J., Kapci M., de Haas R.R., Hoekman K., Verheul H.M., et al. Proteomics of the TRAP-induced platelet releasate. J Proteomics 2009, 72:91-109.
47. Thornton P., McColl B.W., Greenhalgh A., Denes A., Allan S.M., Rothwell N.J. Platelet interleukin-1α drives cerebrovascular inflammation. Blood 2010, 115:3632-3639.
48. Totani L., Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol 2010, 30:2357-2361.
49. Fong K.P., Barry C., Tran A.N., Traxler E.A., Wannemacher K.M., Tang H.Y., et al. Deciphering the human platelet sheddome. Blood 2011, 117:15-26.
50. Andre P., Nannizzi-Alaimo L., Prasad S.K., Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002, 106:896-899.
51. Rahman M., Zhang S., Chew M., Ersson A., Jeppsson B., Thorlacius H. Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury. Ann Surg 2009, 250:783-790.
52. Skinner M.P., Fournier D.J., Andrews R.K., Gorman J.J., Chesterman C.N., Berndt M.C. Characterization of human platelet GMP-140 as a heparin-binding protein. Biochem Biophys Res Commun 1989, 164:1373-1379.
53. Andrews R.K., Gorman J.J., Booth W.J., Corino G.L., Castaldi P.A., Berndt M.C. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the α-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate. Biochemistry 1989, 28:8326-8336.
54. Semeraro F., Ammollo C.T., Morrissey J.H., Dale G.L., Friese P., Esmon N.L., et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011, 118:1952-1961.
55. Beaulieu L.M., Freedman J.E. Inflammation & the platelet histone trap. Blood 2011, 118:1714-1715.
56. Ward C.M., Tetaz T.J., Andrews R.K., Berndt M.C. Binding of the von Willebrand factor A1 domain to histone. Thromb Res 1997, 86:469-477.
57. Saffarzadeh M., Juenemann C., Queisser M.A., Lochnit G., Barreto G., Galuska S.P., et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012, 7:e32366.
58. Megens R.T., Vijayan S., Lievens D., Doring Y., van Zandvoort M.A., Grommes J., et al. Presence of luminal neutrophil extracellular traps in atherosclerosis. Thromb Haemost 2012, 107:597-598.
59. Wang Y., Li M., Stadler S., Correll S., Li P., Wang D., et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009, 184:205-213.
60. Connolly G.C., Khorana A.A., Kuderer N.M., Culakova E., Francis C.W., Lyman G.H. Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res 2010, 126:113-118.
61. Palandri F., Polverelli N., Catani L., Ottaviani E., Baccarani M., Vianelli N. Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study. Ann Hematol 2011, 90:933-938.
62. Kroll M.H., Hellums J.D., McIntire L.V., Schafer A.I., Moake J.L. Platelets and shear stress. Blood 1996, 88:1525-1541.
63. Nesbitt W.S., Westein E., Tovar-Lopez F.J., Tolouei E., Mitchell A., Fu J., et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009, 15:665-673.
64. Al-Tamimi M., Tan C.W., Qiao J., Pennings G.J., Javadzadegan A., Yong A.S., et al. Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels. Blood 2012, 119:4311-4320.
65. Rauova L., Hirsch J.D., Greene T.K., Zhai L., Hayes V.M., Kowalska M.A., et al. Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia. Blood 2010, 116:5021-5031.
66. Rauova L., Zhai L., Kowalska M.A., Arepally G.M., Cines D.B., Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 2006, 107:2346-2353.
67. Chen K, Nishi H, Travers R, Tsuboi N, Martinod K, Wagner DD, Stan R, Croce K, Mayadas TN. Endocytosis of soluble immune complexes leads to their clearance by FcγRIIIB but induces neutrophil extracellular traps via FcγRIIA in vivo. Blood in press.
68. Holdenrieder S., Stieber P. Clinical use of circulating nucleosomes. Crit Rev Clin Lab Sci 2009, 46:1-24.
69. Fuchs T.A., Kremer Hovinga J.A., Schatzberg D., Wagner D.D., Lammle B. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 2012, 120:1157-1164.
70. Thomas G.M., Carbo C., Curtis B.R., Martinod K., Mazo I.B., Schatzberg D., et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 2012, 119:6335-6343.
71. Caudrillier A., Kessenbrock K., Gilliss B.M., Nguyen J.X., Marques M.B., Monestier M., et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012, 122:2661-2671.
72. Bompiani K.M., Monroe D.M., Church F.C., Sullenger B.A. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity. J Thromb Haemost 2012, 10:870-880.
73. Nimjee S.M., Oney S., Volovyk Z., Bompiani K.M., Long S.B., Hoffman M., et al. Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin. RNA 2009, 15:2105-2111.
74. Sachais B.S., Litvinov R.I., Yarovoi S.V., Rauova L., Hinds J.L., Rux A.H. Dynamic antibody binding properties in the pathogenesis of HIT. Blood 2012, 120:1137-1142.